Privigen 10% vial 100ML
Ended Awarded
- Contract number
- SPE2DB25FAZJT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,672
Award facts
- Contract value 100% obligated
- $29,671.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29.7K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for PRIVIGEN 10% Vial 100ML with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a single pharmaceutical product delivery under DMS Pharmaceutical Group's broader contracting relationship with DLA. The award is part of DMS Pharmaceutical Group's significant Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026, which authorizes the issuance of delivery orders for comprehensive pharmaceutical supplies supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, specializing in distributing branded and generic prescription drugs, biologics, vaccines, and medical consumables to Department of Defense healthcare sites. The company's extensive contract portfolio demonstrates consistent success in securing pharmaceutical delivery orders across diverse product categories, including oncology treatments, specialty medications, and immunological products. This delivery order for PRIVIGEN, an immunoglobulin therapy product, exemplifies the company's role in supplying specialized pharmaceutical products essential to military medical operations.
Quick answers
Who was awarded contract SPE2DB25FAZJT?
SPE2DB25FAZJT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FAZJT worth?
The government has obligated $29,672 on SPE2DB25FAZJT.
Is contract SPE2DB25FAZJT an order under another contract?
Yes. SPE2DB25FAZJT is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZJT competed?
The extent of competition for SPE2DB25FAZJT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award